Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.virol.2005.12.006
DC FieldValue
dc.titleInhibition of porcine circovirus type 2 replication in mice by RNA interference
dc.contributor.authorLiu, J.
dc.contributor.authorChen, I.
dc.contributor.authorChua, H.
dc.contributor.authorDu, Q.
dc.contributor.authorKwang, J.
dc.date.accessioned2016-11-28T10:20:34Z
dc.date.available2016-11-28T10:20:34Z
dc.date.issued2006-04-10
dc.identifier.citationLiu, J., Chen, I., Chua, H., Du, Q., Kwang, J. (2006-04-10). Inhibition of porcine circovirus type 2 replication in mice by RNA interference. Virology 347 (2) : 422-433. ScholarBank@NUS Repository. https://doi.org/10.1016/j.virol.2005.12.006
dc.identifier.issn00426822
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/131466
dc.description.abstractPorcine circovirus type 2 (PCV2) is the primary causative agent of an emerging swine disease, postweaning multisystemic wasting syndrome (PMWS) for which no antiviral treatment is available. To exploit the possibility of using RNA interference (RNAi) as a therapeutic approach against the disease, plasmid-borne short hairpin RNAs (shRNAs) were generated to target the PCV2 genome. Transfection of these shRNAs into cultured PK15 cells caused a significant reduction in viral RNA production that was accompanied by inhibiting viral DNA replication and protein synthesis in infected cells. The effect was further tested in vivo in a mouse model that has been developed for PCV2 infection. Mice injected with shRNA before PCV2 infection showed substantially decreased microscopic lesions in inguinal lymph nodes compared to controls. In situ hybridization and immunohistochemical analyses showed that shRNA caused a significant inhibition in the level of viral DNA and protein synthesis detected in the lymph nodes of the treated mice relative to the controls. Taken together, these results indicate that shRNAs are capable of inhibiting PCV2 infection in vitro as well as in vivo and thus may constitute an effective therapeutic strategy for PCV2 infection. © 2005 Elsevier Inc. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.virol.2005.12.006
dc.sourceScopus
dc.subjectDNA replication
dc.subjectMouse
dc.subjectPorcine circovirus type 2 (PCV2)
dc.subjectProtein synthesis
dc.subjectRNA interference (RNAi)
dc.subjectshRNA
dc.typeArticle
dc.contributor.departmentBIOLOGICAL SCIENCES
dc.contributor.departmentMICROBIOLOGY
dc.description.doi10.1016/j.virol.2005.12.006
dc.description.sourcetitleVirology
dc.description.volume347
dc.description.issue2
dc.description.page422-433
dc.description.codenVIRLA
dc.identifier.isiut000237196600017
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.